Conditions: Healthy Volunteer
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 34
Healthy volunteers: yes

Brief summary:
To evaluate the safety and tolerability of LY3009104 when given orally as single and multiple doses in Japanese healthy subjects.

Detailed description:

Arms:
arm 1: 2mg administered once on day 1 (single dose) arm 2: 5mg administered once on day 1 (single dose) arm 3: 10 mg administered on day 1 (single dose) and following a 7 day washout period, administered once daily for 10 days (multiple dose) arm 4: 14 mg administered on day 1 (single dose) and following a 7 day washout period, administered once daily for 10 days (multiple dose) arm 5: administered on day 1 (single dose) and following a 7 day washout period, administered once daily for 10 days (multiple dose)

Interventions: intervention 1: LY3009104 intervention 2: Placebo
Intervention descriptions: intervention 1: Administered orally intervention 2: Administered orally

Protocol document: